Infectious Diseases Society of America (IDSA) President Barbara Murray addressed the House Energy and Commerce Subcommittee on Friday and applauded the White House executive order regarding an approach to dealing with antibiotic resistance.
Murray said that the White House's National Strategy for combating antibiotic resistance "...adds to an impressive chorus of experts clamoring for substantial politics to address antibiotic resistance."
In her statement, Murray claimed that significant barriers prevent needed antibiotics from being manufactured for patients. These barriers to research and development prove deadly for many patients, and Murray said that the Antibiotic Development to Advance Patient Treatment Act (ADAPT) is a crucial step toward removing those barriers.
In addition to ADAPT, Murray called for more economic incentives for development and research of antibiotics such as tax credits and more funding for federal agencies.
"IDSA is calling for a requirement that all healthcare facilities implement an antibiotic stewardship program as a condition of participation in Medicare," Murray.
Murray cited the need to understand the diseases facing the country and world today by promoting the clinical integration of new diagnostics.